Avanos Medical, Inc. financial data

Symbol
AVNS on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
5405 Windward Parkway, Suite 100 South, Alpharetta, GA
State of incorporation
DE
Fiscal year end
December 31
Former names
Halyard Health, Inc. (to 6/28/2018)
Latest financial report
10-Q - Q3 2024 - Oct 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 221 % -28.7%
Quick Ratio 76 % -18.8%
Debt-to-equity 35.6 % -3.65%
Return On Equity 1.28 %
Return On Assets 0.94 %
Operating Margin 4.92 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46M shares -1.01%
Common Stock, Shares, Outstanding 46M shares -1.01%
Entity Public Float 1.19B USD -6.83%
Common Stock, Value, Issued 500K USD 0%
Weighted Average Number of Shares Outstanding, Basic 46M shares -1.71%
Weighted Average Number of Shares Outstanding, Diluted 46.6M shares -0.43%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 682M USD +5.91%
Research and Development Expense 27.3M USD +0.74%
Operating Income (Loss) 33.5M USD +900%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 26.1M USD
Income Tax Expense (Benefit) 4.4M USD -20%
Net Income (Loss) Attributable to Parent 15.7M USD
Earnings Per Share, Basic 0.35 USD/shares
Earnings Per Share, Diluted 0.34 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 89M USD -16.9%
Inventory, Net 162M USD +3.38%
Assets, Current 473M USD -9.91%
Deferred Income Tax Assets, Net 6.6M USD +53.5%
Property, Plant and Equipment, Net 110M USD -6.25%
Operating Lease, Right-of-Use Asset 26.5M USD -2.21%
Intangible Assets, Net (Excluding Goodwill) 220M USD -9.13%
Goodwill 795M USD +0.46%
Other Assets, Noncurrent 25.8M USD +40.2%
Assets 1.66B USD -3.98%
Accounts Payable, Current 54.2M USD +4.03%
Accrued Liabilities, Current 82.7M USD -14.9%
Liabilities, Current 213M USD +24.7%
Deferred Income Tax Liabilities, Net 23.9M USD -16.7%
Operating Lease, Liability, Noncurrent 26.5M USD -10.2%
Other Liabilities, Noncurrent 10.6M USD -32.1%
Liabilities 427M USD -15.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -36.9M USD -11.8%
Retained Earnings (Accumulated Deficit) -310M USD +4.83%
Stockholders' Equity Attributable to Parent 1.23B USD +0.62%
Liabilities and Equity 1.66B USD -3.98%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8M USD -17.6%
Net Cash Provided by (Used in) Financing Activities -700K USD +96.8%
Net Cash Provided by (Used in) Investing Activities -2M USD +50%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.9M USD +62.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 89M USD -16.9%
Deferred Tax Assets, Valuation Allowance 4.3M USD -52.2%
Deferred Tax Assets, Gross 57.7M USD -2.7%
Operating Lease, Liability 41.1M USD -7.64%
Depreciation 20.6M USD +18.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 11.8M USD
Lessee, Operating Lease, Liability, to be Paid 48.2M USD -9.4%
Property, Plant and Equipment, Gross 247M USD +4.93%
Operating Lease, Liability, Current 13.7M USD +7.87%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.3M USD +1.09%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.5M USD +3.85%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.7M USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 10.3M USD -43.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.2M USD -10.1%
Additional Paid in Capital 1.67B USD +0.9%
Amortization of Intangible Assets 25.3M USD +3.27%
Depreciation, Depletion and Amortization 11.4M USD -5.79%
Deferred Tax Assets, Net of Valuation Allowance 53.4M USD +6.16%
Share-based Payment Arrangement, Expense 14M USD -11.4%
Interest Expense 14.6M USD +19.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%